Orange County Business Journal

HEALTHCARE

Recent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...

Solis Gets Stake in Lindora

Newport Beach-based private equity firm Solis Capital Partners has acquired an equity stake in Lindora Inc., a Costa Mesa-based provider of weight-loss management programs.

By Jane Yu February 13, 2015 9:51 a.m.   Share
Tease photo

2 OC Hospitals on Top 50 List

Saddleback Memorial Medical Center, with campuses in Laguna Hills and San Clemente, placed among the top 50 hospitals in America, according to review organization Healthgrades Operating Co. Inc.

Tease photo

Pyott in Line for $100M Payout

Allergan Inc. Chief Executive David Pyott is in line for a severance payment of $100 million as a result of Actavis PLC’s pending buy of the Irvine-based drug maker, according to a federal filing.

Quality’s New Quantity

Adoption of Electronic Medical Records Prompts Diversification at Software Maker

Quality Systems Inc. has gone from darling to diversification, and the shift in gears looks to be giving the Irvine-based medical software maker and its shares a shot in the arm.

Pyott’s Victory Lap; New at Modo Mio; Just-Right Joyce

You heard it here first back in November, when the Insider picked up on vibes that Actavis PLC might take the Allergan name once it got its deal for the Irvine-based drugmaker done.

Allergan Brand Equity Seen as Key to Top Billing

HEALTHCARE: Name better known than buyer in $71B deal

Actavis PLC’s recent decision to take on the name and ticker symbol of Allergan Inc. after it completes its $70 billion acquisition of the Irvine-based drugmaker next month brought plaudits from the local business community, where the move was hailed as a worthy acknowledgment and good business sense.

Harvard Makes Case Study of Hoag Orthopedic Institute

HEALTHCARE: Reform key context for research, report

How is the 5-year-old joint venture between nonprofit Hoag Memorial Hospital Presbyterian and a pair of doctors’ groups going?

For-Profit Hospitals Steady in Wake of Federal Reform

HEALTHCARE: Continued role seen for group

Nonprofit hospital affiliations and network creation in the wake of federal healthcare reform have dominated Orange County’s hospital headlines in recent months.

Octane Head Leaves for San Diego

Matthew Jenusaitis will step down as president and chief executive of Aliso Viejo-based Octane to join the University of California San Diego Healthcare System.

Irvine-Based REIT Discusses Probe of Biggest Tenant

HCP Says Nursing Home Operator Cooperating

Executives at Irvine-based HCP Inc. are standing behind their largest tenant, which is being investigated by the Department of Justice and several other federal agencies.

Tease photo

Architect Gives to SC Hospital Effort

Lawrence Armstrong, a San Clemente resident and chief executive of Irvine-based architecture and planning firm Ware Malcomb, said today that his firm will donate $250,000 worth of design and planning services to keep the current Saddleback Memorial Medical Center San Clemente campus open.

Tease photo

St. Joseph Health Boss to Retire

Irvine-based St. Joseph Health said today that longtime Chief Executive Deborah Proctor will retire from her post at the end of 2015.

Tease photo

Octane CEO Headed to UCSD

Matthew Jenusaitis will step down as president and chief executive of Aliso Viejo-based Octane to join the University of California San Diego Healthcare System.

Tease photo

Top Billing for Allergan Name

The Allergan name will remain the calling card of the company that will be formed after the Irvine-based drug maker’s estimated $69 billion acquisition by Dublin-based Actavis Plc.

Tease photo

ReShape Raises More Money

San Clemente-based device maker ReShape Medical Inc. raised $6.75 million in debt financing, according to a Securities and Exchange Commission filing.

Tease photo

Masimo Beats on Q4

Irvine patient monitor maker Masimo Corp. reported financial results after markets closed Tuesday that surpassed Wall Street expectations.